Working PaperReviewVersion 1This version is not peer-reviewed
The Alterations of Cellular Signaling Pathways in the Host Cell upon the High Pathogenic Coronaviruses Infection, SARS-CoV and MERS-CoV. What Could Be Expected from the SARS-CoV-2?
Version 1
: Received: 17 September 2020 / Approved: 21 September 2020 / Online: 21 September 2020 (04:17:24 CEST)
How to cite:
Hemmat, N.; Asadzadeh, Z.; Karim-ahangar, N.; Alemohammad, H.; Najafzadeh, B.; Derakhshani, A.; Baghbanzadeh, A.; Bannazadeh Baghi, H.; Javadrashid, D.; Najafi, S.; Ar Gouilh, M.; Baradaran, B. The Alterations of Cellular Signaling Pathways in the Host Cell upon the High Pathogenic Coronaviruses Infection, SARS-CoV and MERS-CoV. What Could Be Expected from the SARS-CoV-2?. Preprints2020, 2020090489
Hemmat, N.; Asadzadeh, Z.; Karim-ahangar, N.; Alemohammad, H.; Najafzadeh, B.; Derakhshani, A.; Baghbanzadeh, A.; Bannazadeh Baghi, H.; Javadrashid, D.; Najafi, S.; Ar Gouilh, M.; Baradaran, B. The Alterations of Cellular Signaling Pathways in the Host Cell upon the High Pathogenic Coronaviruses Infection, SARS-CoV and MERS-CoV. What Could Be Expected from the SARS-CoV-2?. Preprints 2020, 2020090489
Cite as:
Hemmat, N.; Asadzadeh, Z.; Karim-ahangar, N.; Alemohammad, H.; Najafzadeh, B.; Derakhshani, A.; Baghbanzadeh, A.; Bannazadeh Baghi, H.; Javadrashid, D.; Najafi, S.; Ar Gouilh, M.; Baradaran, B. The Alterations of Cellular Signaling Pathways in the Host Cell upon the High Pathogenic Coronaviruses Infection, SARS-CoV and MERS-CoV. What Could Be Expected from the SARS-CoV-2?. Preprints2020, 2020090489
Hemmat, N.; Asadzadeh, Z.; Karim-ahangar, N.; Alemohammad, H.; Najafzadeh, B.; Derakhshani, A.; Baghbanzadeh, A.; Bannazadeh Baghi, H.; Javadrashid, D.; Najafi, S.; Ar Gouilh, M.; Baradaran, B. The Alterations of Cellular Signaling Pathways in the Host Cell upon the High Pathogenic Coronaviruses Infection, SARS-CoV and MERS-CoV. What Could Be Expected from the SARS-CoV-2?. Preprints 2020, 2020090489
Abstract
Emerging viruses description have grown at an unprecedented rate since the beginning of the 21st century. The emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its related illness, Coronavirus Disease 2019 (COVID-19) has been reported as the third highly pathogenic coronavirus introducing itself into human population in the current era after the SARS-CoV and Middle East Respiratory Syndrome (MERS-CoV). Molecular and cellular studies considering the pathogenesis of this novel coronavirus are still in the early stages of research, however, regarding the similarity of SARS-CoV-2 and other coronaviruses, it could be hypothesized that the NF-κB, Cytokine regulation, ERK, and TNF-α signaling pathways are the more likely causes of inflammation upon onset of COVID-19. There are several drugs prescribed and used to alleviate the activity of these inflammatory cellular signaling pathways which might be beneficial for developing novel therapeutic modalities against COVID-19. In this review, we briefly summarized the alteration of cellular signaling pathways affected by coronavirus infection, particularly SARS-CoV and MERS-CoV and tabulated the current therapeutic agents approved for previous human diseases.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
